These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
346 related items for PubMed ID: 23436070
1. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients. Varrone A, Mattsson P, Forsberg A, Takano A, Nag S, Gulyás B, Borg J, Boellaard R, Al-Tawil N, Eriksdotter M, Zimmermann T, Schultze-Mosgau M, Thiele A, Hoffmann A, Lammertsma AA, Halldin C. Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):921-31. PubMed ID: 23436070 [Abstract] [Full Text] [Related]
4. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand. Tan Z, Haider A, Zhang S, Chen J, Wei J, Liao K, Li G, Wei H, Dong C, Ran W, Li Y, Li Y, Rong J, Li Y, Liang SH, Xu H, Wang L. Pharmacol Res; 2023 Mar; 189():106681. PubMed ID: 36746361 [Abstract] [Full Text] [Related]
5. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106. Takano A, Piehl F, Hillert J, Varrone A, Nag S, Gulyás B, Stenkrona P, Villemagne VL, Rowe CC, Macdonell R, Tawil NA, Kucinski T, Zimmermann T, Schultze-Mosgau M, Thiele A, Hoffmann A, Halldin C. EJNMMI Res; 2013 Apr 24; 3(1):30. PubMed ID: 23618062 [Abstract] [Full Text] [Related]
6. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice. Liu B, Le KX, Park MA, Wang S, Belanger AP, Dubey S, Frost JL, Holton P, Reiser V, Jones PA, Trigg W, Di Carli MF, Lemere CA. J Neurosci; 2015 Nov 25; 35(47):15716-30. PubMed ID: 26609163 [Abstract] [Full Text] [Related]
9. Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain. Feeney C, Scott G, Raffel J, Roberts S, Coello C, Jolly A, Searle G, Goldstone AP, Brooks DJ, Nicholas RS, Trigg W, Gunn RN, Sharp DJ. Eur J Nucl Med Mol Imaging; 2016 Nov 25; 43(12):2201-2210. PubMed ID: 27349244 [Abstract] [Full Text] [Related]
10. Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein. Lyoo CH, Ikawa M, Liow JS, Zoghbi SS, Morse CL, Pike VW, Fujita M, Innis RB, Kreisl WC. J Nucl Med; 2015 May 25; 56(5):701-6. PubMed ID: 25766898 [Abstract] [Full Text] [Related]
11. Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding. Guo Q, Colasanti A, Owen DR, Onega M, Kamalakaran A, Bennacef I, Matthews PM, Rabiner EA, Turkheimer FE, Gunn RN. J Nucl Med; 2013 Nov 25; 54(11):1915-23. PubMed ID: 24071511 [Abstract] [Full Text] [Related]
12. In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain. Yan X, Siméon FG, Liow JS, Morse CL, Montero Santamaria JA, Jenkins M, Manly LS, Van Buskirk M, Zoghbi SS, Pike VW, Innis RB, Zanotti-Fregonara P. Eur J Nucl Med Mol Imaging; 2023 Aug 25; 50(10):2962-2970. PubMed ID: 37249618 [Abstract] [Full Text] [Related]
13. Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study. Takano A, Gulyás B, Varrone A, Karlsson P, Sjoholm N, Larsson S, Jonsson C, Odh R, Sparks R, Al Tawil N, Hoffmann A, Zimmermann T, Thiele A, Halldin C. Eur J Nucl Med Mol Imaging; 2011 Nov 25; 38(11):2058-65. PubMed ID: 21732107 [Abstract] [Full Text] [Related]
14. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers. Lavisse S, García-Lorenzo D, Peyronneau MA, Bodini B, Thiriez C, Kuhnast B, Comtat C, Remy P, Stankoff B, Bottlaender M. J Nucl Med; 2015 Jul 25; 56(7):1048-54. PubMed ID: 26025960 [Abstract] [Full Text] [Related]